Pharmaceuticals
OPKO Health, Inc. is a global healthcare company founded in 2007 that develops pharmaceuticals, diagnostics, and biomedical solutions to address critical health needs. The company's OPKO Pharmaceuticals division focuses on specialty treatments, including Rayaldee® (calcifediol), a first-in-class product for treating stage 3 or 4 chronic kidney disease with secondary hyperparathyroidism and Vitamin D insufficiency. With over 5,500 employees spanning nine countries, OPKO has grown through organic expansion and strategic acquisitions while maintaining an entrepreneurial culture that emphasizes innovation, transparent communication, and a team-first approach.
Industry
Pharmaceuticals
Company Size
5001-10000 employees
Founded
2007
Beta · Sourced from candidate reports
Be the first to share your experience with OrthoVirginia.
Your reply helps other candidates know what to expect.
